Creation of a novel therapeutic antibody for tumor metastasis-Targeting Tumor Vasculogenic Mimicry-
Creation of a novel therapeutic antibody for tumor metastasis-Targeting Tumor Vasculogenic Mimicry-
批准号:
22890192
负责人:
NOMURA Tetsuya
金额:
$2.01万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Research Activity Start-up
财政年份:
2010
资助国家:
日本
项目状态:
已结题
起止时间:
2010 至 2011
中文摘要
点击翻译按钮获取中文摘要
英文摘要
In this study, we had an attempt to develop a novel therapy for tumor. Recent years, it is reported that in the tumor tissue tumor cells compose luminal structure as like vessel. This structure is called as tumor vasculogenic mimicry(TVM). There are many red blood cells in a part of TVM. It is expected that TVM has an important role to metastasize via blood flow. Therefore, it expects that the inhibition of both angiogenesis and TVM can result in the inhibition of tumor growth and metastasis. Therefore, we had an attempt to create anti-TVM antibody for tumor therapy, using phage-display technique. Next, we evaluated tumor growth suppressive effect by TVM vaccine therapy for tumor bearing mice to clarify how TVM development associates with metastasis. As the result, in TVM-immune mice, tumor growth had a tendency to be suppressed, compared with non-treated mice. In addition, to evaluate TVM property as blood vessel, we measured enzyme activity which has high activity in endothelial cell. As the result, in TVM, we can't confirm the elevated activity. Thus, we clarified that TVM possess properties differing from blood vessel in spite of being similar in structure to them.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Arsenic trioxide induces down-regulation of gp46 via protein oxidation : proteomics analysis of oxidative modified proteins in As2O3-treated HTLV-1-infected cells.
三氧化二砷通过蛋白质氧化诱导 gp46 下调:As2O3 处理的 HTLV-1 感染细胞中氧化修饰蛋白质的蛋白质组学分析。
DOI:
--
发表时间:
2010
期刊:
Pharmazie
影响因子:
1.6
作者:
[Nabeshi H., Kamada H., et al.]
通讯作者:
et al.
DDS技術を駆使した腫瘍組織血管標的がん免疫療法の開発
利用DDS技术开发针对肿瘤组织和血管的癌症免疫疗法
DOI:
--
发表时间:
2011
期刊:
Drug Delivery System
影响因子:
--
作者:
[田所由利子, 江藤宏美, 片岡弥恵子, 八重ゆかり, 浅井宏美, 飯田真理子, 櫻井綾香, 堀内成子, 根橋佳奈, 澤田啓介, 厚味厳一, 野村鉄也]
通讯作者:
野村鉄也
トランスフェリンリポソームによる細胞内送達とがん治療への応用
使用转铁蛋白脂质体进行细胞内递送及其在癌症治疗中的应用
DOI:
--
发表时间:
2011
期刊:
人工血液
影响因子:
--
作者:
[Nomura T, Abe Y, Kamada H, Shibata H, Kayamuro H, Inoue M, Kawara T, Arita S, Furuya T, Yamashita T, Nagano K, Yoshikawa T, Yoshioka Y, Mukai Y, Nakagawa S, Taniai M, Ohta T, Serada S, Naka T, Tsunoda SI, Tsutsumi Y, 平田圭一]
通讯作者:
平田圭一
Vaccination with tumor endothelial cells isolated from solid tumor inhibits tumor growth and angiogenesis
使用从实体瘤中分离的肿瘤内皮细胞进行疫苗接种可抑制肿瘤生长和血管生成
DOI:
--
发表时间:
2011
期刊:
影响因子:
--
作者:
[Kayamuro H, Yoshioka Y, Abe Y, Arita S, Katayama K, Nomura T, Yoshikawa T, Kubota-Koketsu R, Ikuta K, Okamoto S, Mori Y, Kunisawa J, Kiyono H, Itoh N, Nagano K, Kamada H, Tsutsumi Y, Tsunoda S, Nomura T]
通讯作者:
Nomura T
DOI:
10.1128/jvi.01182-10
发表时间:
2010-12-01
期刊:
JOURNAL OF VIROLOGY
影响因子:
5.4
作者:
[Kayamuro, Hiroyuki, Yoshioka, Yasuo, Tsunoda, Shin-Ichi]
通讯作者:
Tsunoda, Shin-Ichi
共 9 条
Identification of novel receptor-selective cytokine to overcome tumor immune escape mechanisms
-
批准号:17K18115
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.75万
-
财政年份:2017
-
负责人:NOMURA Tetsuya
-
依托单位:
Development of novel DDS drugs targeting for glioma tumor vasculogenic mimicry
-
批准号:24790050
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.83万
-
财政年份:2012
-
负责人:NOMURA Tetsuya
-
依托单位:
The Study for the husband-wife relationships
-
批准号:60301025
-
项目类别:Grant-in-Aid for Co-operative Research (A)
-
资助金额:$5.12万
-
财政年份:1985
-
负责人:NOMURA Tetsuya
-
依托单位: